반응식
F[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1[S:8](Cl)(=[O:10])=[O:9].[NH2:12][C:13]1[CH:14]=[N:15][C:16]([O:19][CH3:20])=[N:17][CH:18]=1.[Cl:21][C:22]1[CH:29]=[CH:28][CH:27]=[C:26]([F:30])[C:23]=1[CH2:24][NH2:25]>O1CCOCC1.CC#N>[Cl:21][C:22]1[CH:29]=[CH:28][CH:27]=[C:26]([F:30])[C:23]=1[CH2:24][NH:25][C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1[S:8]([NH:12][C:13]1[CH:14]=[N:15][C:16]([O:19][CH3:20])=[N:17][CH:18]=1)(=[O:10])=[O:9]참가 물질
6
실험 절차
The title compound (106 mg, impure, used without further purification) was prepared in two steps from 2-fluorobenzenesulfonyl chloride (0.46 mL, 3.5 mmol) and 5-amino-2-methoxypyrimidine (482 mg, 3.85 mmol) in 1,4-dioxane at 100° C.; followed by 2-chloro-6-fluorobenzyl amine (0.36 mL, 2.8 mmol) in MeCN (1.5 mL) at 180° C. in a Biotage Initiator microwave reactor using the methods of (IntB1).
출처 및 근거
- ORD 기록
- ord-b2ab220cfe2c403abf927cfa50f04389
- 출처 데이터셋
- uspto-grants-2016_02
- 특허 번호
- US09249160B2
연결된 노트
불러오는 중…